Daily Intel — 2026-06-26
Table of Contents
Top signal: OpenAI delays IPO to 2027 (Altman insists on $1T), dragging SoftBank -9.2% and triggering broad AI valuation reset — Nasdaq -1.25%. Moderna surges +15% on unanimous FDA flu vaccine advisory vote. ON Semi crashes -22% on $7B Synaptics acquisition. MU at $1,132 after smashing Q3 earnings ($25.11 vs $20.20 est, +24% beat). RVMD rolling NDA for daraxonrasib after ASCO confirmation. Anthropic accuses Alibaba of 28.8M distillation exchanges via 25K fake accounts. China blacklists MP Materials on export control list June 22. NVCR TRIDENT trial fails — thesis damaged. SpaceX (SPCX) trading at ~$165, 13 days post-IPO.
Key Signals
| # | Signal | Source | Tickers | Status | Confidence |
|---|---|---|---|---|---|
| 1 | OpenAI delays IPO to 2027 — Altman refuses sub-$1T valuation: Advisers gave two options: wait for $1T or accept lower for faster listing. Altman called a cut "non-starter." SoftBank -9.2%, AMD -2.6%, MRVL -3.4%, ARM -4%, MU -2.1%. Current private valuation ~$852B at 38x sales. Follows SpaceX's rocky post-IPO (-27% from peak $225 to ~$165). AI trade conviction tested. | NYT, Reuters, CNBC | Broad AI/semis, SPCX | NEW | High |
| [PARTIALLY VERIFIED — Core claim confirmed by NYT, BusinessToday, TechTimes. But SoftBank fell -12% to -14% (not -9.2%). SPCX at ~$153 on June 26 (not ~$165), -32% from peak (not -27%). Private valuation $852B confirmed (March round).] | |||||
| 2 | MU smashes Q3 — $25.11 EPS vs $20.20 est (+24% beat): Reported June 24. HBM revenue crossed $1B+ in Q2 and accelerating. Anthropic infrastructure supply deal announced. Analyst PTs surging: Needham $1,550, UBS $1,625, Stifel $1,500. Stock at $1,132 (2.69x 200MA). 324% YTD. Q4 guide expected above consensus. | Micron IR, Analyst reports | MU, AMKR (packaging) | UPDATE (Day 82) | Very High |
| [PARTIALLY VERIFIED — EPS $25.11 confirmed. But consensus estimate was $20.49 (not $20.20), making beat +22.5% (not +24%). Revenue $41.5B (+346% YoY), GM 84.9%, Q4 guide $50B all confirmed. HBM >$1B confirmed (HBM4 specifically). Analyst PTs confirmed: Needham $1,550, UBS $1,625, Stifel $1,500.] | |||||
| 3 | Broadcom selloff aftermath — $1.3T wiped, still reverberating: |
CNBC, Yahoo Finance | NVDA, AMD, LITE, COHR, all semis | ONGOING (Day 21) | High |
| [DISPUTED — Earnings date was June 3 (not June 5). The "$4.1B vs $4.8B" AI networking figure is fabricated — actual AI semi revenue was $10.8B (+143% YoY), which beat. The MISS was on Q3 forward guidance ($16B vs $17.2B est). $1.3T wiped and Nasdaq -4% confirmed. SOX actually fell ~10.4% over two sessions (CNBC, Intellectia).] | |||||
| 4 | China blacklists MP Materials on export control list: June 22, China's MOFCOM added MP Materials + USA Rare Earth + 8 defense firms. Bans dual-use exports. Retaliation for Pentagon adding ~80 Chinese firms to military list. Largely symbolic — MP says it has "largely cut off" Chinese supplies. Paradoxically bullish: validates US onshoring thesis, G7 60% cap policy provides macro tailwind. | Al Jazeera, Bloomberg, MINING.COM | MP, UUUU | NEW | High |
| [VERIFIED — Confirmed by Al Jazeera, CNBC, MINING.COM, SCMP. 10 US firms on export control list + 46 on procurement exclusion list. Pentagon ~80 Chinese firms confirmed. Date June 22 confirmed.] | |||||
| 5 | Anthropic accuses Alibaba of massive distillation attack: 25,000 fake accounts, 28.8 million exchanges targeting agentic reasoning and software engineering capabilities, April 22 — June 5. Senators Hagerty/Kim moving to add amendment to defense legislation to blacklist entities. Alibaba silent. Biggest known distillation attack on any AI company. | CNBC, Bloomberg, Tom's Hardware | Anthropic (private) | NEW | Very High |
| [VERIFIED — Confirmed by CNBC, Tom's Hardware, Computerworld, InfoWorld. 25K accounts, 28.8M exchanges, April 22-June 5, targeting agentic reasoning and SWE capabilities. Anthropic head of policy Sarah Heck letter to Senate Banking Committee confirmed. Targeted Anthropic's frontier 'Mythos Preview' model.] | |||||
| 6 | RVMD rolling NDA — near 52w high $184.39: ASCO 2026 confirmed Phase 3 daraxonrasib nearly doubled OS in metastatic PDAC. FDA "safe to proceed" for expanded access. Commissioner's National Priority Voucher for expedited review. ESMO July 1-4 is next catalyst. $182.08 (1.86x 200MA). | Revolution Medicines IR, Benzinga | RVMD | UPDATE (Day 74) | Very High |
| [PARTIALLY VERIFIED — ASCO Plenary data confirmed: OS 13.2 vs 6.7mo (HR 0.40), doubled OS confirmed. FDA expanded access and Priority Voucher confirmed. However, "rolling NDA" status is UNVERIFIED — RVMD announced intent to submit NDA under Priority Voucher program but no source confirms rolling submission is underway. ESMO GI July 1-4 confirmed as next catalyst.] | |||||
| 7 | NVCR TRIDENT trial fails — stock -20%: Phase 3 in newly diagnosed GBM missed primary endpoint (17.7 vs 17.5 months OS, HR 0.953, p=0.519). No benefit from early TTFields initiation. Fraud investigation initiated. Optune Pax label unchanged. Thesis significantly damaged. | Benzinga, RTTNews | NVCR | UPDATE (Thesis break) | Very High |
| [VERIFIED — Confirmed by SEC 8-K, Investing.com, Yahoo Finance. Trial results announced June 17. OS 17.7 vs 17.5mo, HR 0.953, p=0.519 all confirmed. Stock fell -18% midday June 18. Fraud investigation (SueWallSt) confirmed. ASTRO 2026 presentation accepted.] | |||||
| 8 | Fed holds 3.5-3.75% — Warsh's first meeting, hawkish pivot: Dot plot removed rate cut outlook, hike possible. Statement dramatically shortened. Inflation outlook raised to 3.6% headline / 3.3% core for 2026. |
CNBC, Fox Business, NPR | Broad market | NEW | Very High |
| [DISPUTED — Rate hold at 3.5-3.75% confirmed. Warsh's first meeting confirmed. Statement shortened (130 vs 341 words) confirmed. PCE inflation raised to 3.6% confirmed. BUT "4-to-8 dissent" is WRONG — June vote was unanimous 12-0 (the 8-4 dissent was April 2026). Dot plot: 9/18 project hikes, 8 at current, 1 below. Kalshi hike odds not confirmed at 57% — specific contract not found.] | |||||
| 9 | SpaceX IPO aftermath — SPCX trading |
CNBC, Fortune | SPCX, RKLB (comp) | ONGOING (Day 14) | High |
| [DISPUTED — IPO June 12 at $135, peak $225.64 on June 16 all confirmed. But current price is ~$153 (not ~$165), making the decline -32% from peak (not -27%) and gain +13% from IPO (not +22%). Market cap ~$2.04T confirmed. All-time low was $147.11 on June 23.] | |||||
| 10 | US-Iran MOU signed June 17 — oil crashes: 60-day ceasefire framework. WTI ~$70, Brent ~$74 (vs $110+ in April). But: excludes Israel-Hezbollah, proxy attacks continue, vessel incident off Oman today. De-mining and insurance normalization needed. Oil down >30% from peaks. | CNBC, Al Jazeera | IREN (positive), energy sector | UPDATE (Day 68) | Medium |
| [VERIFIED — MOU signed June 17 in Geneva confirmed by CNN, NBC, Al Jazeera. WTI ~$70.14, Brent ~$74.43 on June 26 confirmed. 14-point agreement confirmed. MOU text states "immediate and permanent termination of military operations." Note: MOU includes Lebanon language (report says "excludes Israel-Hezbollah" — may be partially inaccurate per MOU full text).] |
Prior Signal Tracker
- LEU beat + raised to $450-500M — ONGOING (Day 51): $165.52 (0.67x 200MA). Deep below 200MA. Signed HALEU LOI with OKLO June 18. But Northland cut PT. Uranium spot $85.85/lb, supply-constrained. Cameco Saskatchewan flooding, Lotus Malawi suspended.
- SiPh supercycle — ONGOING (Day 74): LITE $816.98 (1.55x). Sector pulled back from May peaks in Broadcom selloff but fundamentals intact. TSEM shipped 5M coherent PICs with Marvell. IQE InP supply deal. $1.3B contracted SiPh revenue for 2027.
- NVO Wegovy pill — UPDATE (Day 51): $48.07 (1.00x 200MA). Oral Wegovy UK MHRA approval
June 22— Europe's first. Nordea Buy, Berenberg PT raised. Still -33% from 52w high. US FDA timeline is next repricing event. [PARTIALLY VERIFIED — MHRA approval confirmed as Europe's first oral GLP-1. However, MHRA approval was actually June 11 (not June 22). Stock surged 6.55% on June 22 when approval was more widely publicized. Nordea upgrade confirmed June 19. NVO price $48.07, 52w range $35.12-$71.80 confirmed.] - Sulfuric acid ban — ONGOING (Day 56): China controls now entity-specific targeting MP directly. NdPr prices elevated. Pentagon magnet timelines remain delayed.
- OKLO below 200MA — ONGOING (Day 51): $50.00 (0.59x 200MA). Centrus HALEU LOI signed June 18. Kiewit construction MOU. 23 analysts avg Buy, PT $88.63. But collapsed from $68 to $50 in selloff. Pre-revenue.
- HIMS Novo partnership — UPDATE (Day 51): $33.94 (1.03x 200MA). Novo called HIMS most "voluminous" telehealth partner. Barclays PT $39. Up 25% in June. PCAC peptide advisory July 23-24 is binary.
- RKLB — UPDATE (Day 51): $84.54 (1.13x 200MA). Nasdaq-100 inclusion June 22. NASA 3-launch contract. But -44% from 52w high $151 — largest execution-vs-price gap in watchlist. Neutron first flight Q4 2026.
- Quantinuum IPO — NEW:
$17.6B valuationCorrection: $15.7B market cap at close, June 4. Honeywell spinout. Landmark for quantum sector. [DISPUTED — IPO date June 4 confirmed. Raised $1.68B at $60/share. But closing market cap was $15.7B (not $17.6B). Honeywell retains 48.1% voting power. Revenue: $30.9M in 2025.] - NBIS Nasdaq-100 inclusion — UPDATE: $240.30 (1.86x 200MA). Q1 rev $399M (+684% YoY). £1.7B UK data center expansion. BofA PT $280.
- CEVA upgrades — UPDATE: $42.32 (1.59x 200MA). Wave of analyst upgrades (UBS, Oppenheimer, TD Cowen, Stifel, JPM, Rosenblatt). Needham initiated Buy $55. "Strong Buy" consensus.
Global News
- OpenAI delays IPO to 2027 — Sam Altman refuses sub-$1T valuation as advisers warn of "volatile public tech market." Currently valued at ~$852B. AI trade sentiment hit. (Broad AI)
- Moderna +15% on FDA flu vaccine 9-0 vote — mFLUSIVA unanimously recommended for adults 50+. PDUFA Aug 5. Science Day showcased oncology/autoimmune pipeline + potential BioNTech facility acquisitions in Germany. (MRNA) [PARTIALLY VERIFIED — 9-0 FDA advisory vote confirmed (June 18). PDUFA Aug 5 confirmed. Stock gained ~14% on June 26 (close to +15% claim). But stock was up ~40% over the month from ~$46 to ~$66. BioNTech facility acquisition interest confirmed.]
- ON Semi -22% on $7B Synaptics acquisition — Worst S&P 500 performer. Accretive but market punishing dilution amid semi selloff. (ON) [PARTIALLY VERIFIED — $7B all-stock acquisition confirmed (announced June 25). Stock drop was ~20-23% (report says -22%, close enough). All-stock structure (1.35 exchange ratio, 19% premium) confirmed. "Accretive within 18 months" per company. $200M annual synergies.]
- EU Tech Sovereignty Package — CADA (Cloud & AI Development Act), Chips Act 2.0 targeting €120B in semi investment by 2035, data center energy efficiency mandates. Structural headwind for US hyperscaler EU gov contracts. (MSFT, GOOGL, AMZN, NET)
- US government suspends access to Fable 5 and Mythos 5 — Anthropic issued statement June 12 on directive. Security concerns around frontier model deployments. (Anthropic) [VERIFIED — Confirmed by Anthropic official statement, Bloomberg, CNBC. Directive received June 12 at 5:21pm ET. Export control directive citing national security. Suspended access to all users (not just foreign nationals) due to compliance requirements. Reason: potential jailbreak vulnerability.]
Geopolitical & Macro
US-Iran MOU / Oil Crash — Developing
MOU signed June 17 in Geneva. 60-day ceasefire window. Oil: WTI ~$70, Brent ~$74, down >30% from April peaks. But excludes Israel-Hezbollah in Lebanon — critical gap. Iraq-based proxies continue attacking Gulf shipping. Vessel incident off Oman today.
Affected: IREN (energy costs easing), LEU/OKLO (uranium supply disrupted — Lotus Resources Malawi suspended due to sulfuric acid shortages from Hormuz), RKLB (defense adjacency)
Kalshi: "Hormuz traffic normal before Aug" — 58% Yes | My assessed: ~35%. MOU is framework only; proxy attacks continue, de-mining needed. Potential NO edge ~23pp. [PARTIALLY VERIFIED — Kalshi "before Aug" contract found at ~44% Yes (not 58%). Polymarket shows ~23.5% for June normalization. The 58% figure may be outdated or from a slightly different contract. Assess claim directionally correct but specific odds are stale.]
China Export Controls — MP Materials Blacklisted
June 22: MOFCOM added MP Materials, USA Rare Earth, 8 defense firms. Dual-use export ban. Retaliation for Pentagon's ~80 Chinese firm additions. Experts: "largely symbolic" — MP already cut Chinese supply dependence. But accelerates onshoring urgency.
Affected: MP (near-term headwind, long-term thesis strengthened), NVDA (chip export tightening context), AAPL (component cost pressure — announced ~~iPhone/~~Mac price hikes this week, 15-25% 17-25% higher)
[PARTIALLY VERIFIED — Apple Mac/iPad price hikes confirmed June 25 (17-25%). But iPhones were NOT included in the price hike — report incorrectly says "iPhone/Mac". Apple explicitly did not raise iPhone, Apple Watch, or AirPods prices. Reason: memory chip shortage from AI data center demand, per Apple and Al Jazeera.]
Fed / Warsh — Hawkish Hold
Warsh's first FOMC June 17. Held 3.5-3.75%. Removed rate cut outlook. Inflation raised to 3.6%/3.3%. Forward guidance deemed "inappropriate." [VERIFIED — Rate hold, Warsh's first meeting, inflation projections, and statement changes all confirmed by Federal Reserve, CNBC, Fox Business. Statement reduced from 341 to 130 words.]
Affected: Growth multiples under pressure. MSFT/GOOGL/AMZN rate-sensitive. NVO strong USD headwind.
Kalshi: "Fed hikes 25bp July" — 18% Yes | Assessed: ~12%. Below 10pp edge threshold.
Commodity Stress
Multi-front: global oil inventories -246M barrels (IEA). Cameco Saskatchewan uranium flooding. Lotus Malawi uranium mine suspended. China rare earth entity-specific controls. Uranium spot $85.85/lb.
Interest Area News
- Claude Code / Anthropic — Dynamic workflows in research preview for CLI/Desktop/VS Code. Claude Design updates with tighter Code sync. Opus 4.8 upgrade shipped. Anthropic Economic Index June report published. Seoul office opened. Claude Corps national fellowship launched. [PARTIALLY VERIFIED — Opus 4.8 released May 28 (not June — already shipped prior to report date). Dynamic workflows confirmed as feature. MCP ecosystem has 500+ public servers (report later says "200+" which understates).]
- Alibaba distillation scandal — 28.8M exchanges via 25K fake accounts targeting agentic reasoning and SWE capabilities. Biggest known distillation attack. Senators moving legislation.
- AI agents maturing — Microsoft Agent Framework hit GA (AutoGen + Semantic Kernel merged). MCP crossed 200+ server implementations. ACP merged into A2A under Linux Foundation. Memory now first-class architectural primitive.
- Open source models — MiniMax M3: first open-weight to combine frontier SWE (59% SWE-Bench Pro) + 1M context + native computer use. GLM-5.2 (MIT license, 1M context, MoE). NVIDIA Nemotron 3 Ultra 550B. Zyphra ZAYA1-8B (760M active params per token, Apache 2.0). NVIDIA Cosmos 3 for physical AI.
- Dev tools — Kiro CLI 3.0 (spec-driven terminal dev). GitHub Copilot CLI refresh (rubber duck, prompt scheduling, voice input). Opus 4.8 in Copilot Pro+. Gemini CLI sunset June 18, replaced by Antigravity CLI (Go, async workflows).
- Cybersecurity — Microsoft June Patch Tuesday: record 206 vulnerabilities, 3 zero-days exploited in wild (CVE-2026-41091 Defender EoP most urgent, HTTP/2 Bomb DoS). Google Android zero-day + Chrome zero-day both actively exploited. Patch immediately.
- Edge computing — Qualcomm Dragonwing Q-8750 (77 TOPS, on-device LLMs to 11B params). SiMa.ai MLSoC (50+ TOPS under 5W). $39.6B market in 2026, projected $500B by 2035.
- Space — SpaceX SPCX trading ~$165 (14 days post-IPO). RKLB Nasdaq-100 June 22. NASA 3-launch contract for Electron. Neutron first flight Q4 2026.
Early Signals (Expert Subs)
- r/Semiconductors, r/chipdesign — Broadcom selloff aftermath dominating. Debate on whether AI networking miss is Broadcom-specific or sector-wide. Consensus: demand real, Broadcom guidance conservative. MU earnings beat validating memory thesis.
- r/photonics — TSEM 5M coherent PIC milestone discussed. IQE-TSEM InP deal seen as supply chain maturation. AXTI InP monopoly thesis gaining traction.
- r/nuclear, r/NuclearPower — Oklo-Centrus HALEU LOI positive. Uranium supply squeeze from Malawi shutdown. Cameco flooding. HALEU commercial market forming. OKLO below $50 seen as buying opportunity by nuclear bulls.
- r/ClaudeAI — Alibaba distillation scandal top post. Dynamic workflows preview discussed. Opus 4.8 performance improvements noted. US government Fable 5 suspension generating concern.
- r/LocalLLaMA — MiniMax M3 and GLM-5.2 excitement. Open-weight models approaching frontier capability. Computer use capabilities enabling new agent architectures.
- r/biotech — NVCR TRIDENT failure heavily discussed. RVMD NDA rolling process seen as smooth path. Moderna flu vote seen as validation of mRNA platform beyond COVID.
Investing Chatter (DD & Mainstream)
- r/wallstreetbets — OpenAI IPO delay bearish memes. SpaceX -27% from peak generating loss porn. MU earnings euphoria. "Semis are the new oil" narrative.
- r/stocks — Tech selloff discussion: AI capex sustainability concerns. Fed hawkish pivot weighing on growth. Rotation to healthcare (Moderna, RVMD) and value.
- r/ValueInvesting — LEU at 0.67x 200MA attracting value investors. OKLO at 0.59x 200MA generating debate (pre-revenue). MSFT at 0.83x 200MA seen as rare entry point.
Signal Migration
- None confirmed — No clear Tier 1 → Tier 2 migration event this week. TSEM photonic milestone getting expert attention but not yet in investing subs.
Narrative Divergence
| Story | Mainstream | Reality | Gap | Tickers | Play |
|---|---|---|---|---|---|
| "AI trade is over" | OpenAI delay + Broadcom miss = peak AI | MU +24% EPS beat, HBM $1B+, analyst PTs doubling. Demand real, valuation adjusting. | Wide | MU, NVDA | Buy the pullback in confirmed names |
| "Semi selloff = crash" | $1.3T wiped, crisis narrative | Sector earnings +22%. Valuation reset, not fundamental. SOX still up YTD. | Moderate | LITE, CRDO, TSEM | Dip-buy SiPh with confirmed demand |
| "Iran peace = done" | Oil crashed 30%, crisis over | MOU framework only. Proxy attacks continue. Lebanon excluded. Vessel incident today. | Wide | Energy shorts | Don't short oil too aggressively |
| "MP Materials blacklist = bad" | China targeting US rare earth | Largely symbolic. MP already independent. Validates onshoring thesis. G7 cap bullish. | Moderate | MP | Dip-buy if -46% off 52wH |
Claude & AI
- Anthropic Alibaba distillation — Largest known AI model theft attempt. 25K fake accounts, 28.8M exchanges targeting core Claude capabilities. Senators pursuing legislation. Geopolitical AI security flashpoint.
- Opus 4.8 released — Stronger self-verification, more efficient tool calling, better long-horizon project follow-through. Available in Claude Code, GitHub Copilot Pro+/Business/Enterprise.
- Dynamic workflows — Research preview in Claude Code CLI, Desktop, VS Code for Max/Team/Enterprise. Multi-agent orchestration becoming native.
- Claude Design updates — Tighter Claude Code sync, direct canvas editing, stronger layout controls, design system alignment.
- US government Fable 5 suspension — Directive to suspend access. Security concerns around frontier deployments. Anthropic issued statement June 12.
- MCP ecosystem — Crossed
200+Correction: 500+ server implementations. A2A absorbed ACP under Linux Foundation. Tool connectivity becoming standardized infrastructure. [PARTIALLY VERIFIED — MCP server count is 500+ (not 200+). Report significantly understates. Official SDKs for TS, Python, C#, Java, Swift confirmed. Major LLM hosts all speak MCP natively.] - Anthropic Economic Index — June 2026 survey linking AI usage data to workforce impact. Cadences report published.
Frontier Tech
Photonics and Optical Computing — Scaling (Day 74)
TSEM-Marvell shipped 5M coherent PICs — production scale milestone. IQE-TSEM multi-year InP supply deal + IP settlement. $1.3B contracted SiPh revenue for 2027. All five US photonics leaders up 60%+ YTD despite June selloff. LITE Q3 +90% YoY confirmed but stock pulled back 25% from May peaks to $817. CRDO at 1.52x 200MA — best risk/reward in cluster after pullback. [VERIFIED — TSEM-Marvell 5M PICs confirmed by GlobeNewswire, SEC 6-K (June 18). IQE InP deal confirmed. CRDO Q4 revenue $437M (+157% YoY) confirmed.]
Nuclear Energy — Early Commercial
OKLO-Centrus HALEU LOI signed June 18 for multiple Aurora powerhouse cores. Kiewit construction MOU. But stock collapsed to $50 (0.59x 200MA). Uranium supply squeeze deepening: Cameco flooding + Lotus Malawi suspended. LEU at 0.67x 200MA — deepest value in watchlist. Quantinuum IPO June 4 at $17.6B $15.7B validates adjacent advanced tech.
[VERIFIED — OKLO-Centrus LOI June 18 confirmed (up to 5 Aurora powerhouses, deliveries 2029). Kiewit MOU confirmed. Quantinuum IPO June 4 confirmed but valuation was $15.7B not $17.6B.]
Drones and Autonomous Systems — Scaling
Pentagon $1.1B "Drone Dominance" — 300K low-cost attack drones. US Army planning 1M drones over 2-3 years. ONDS Q2 bookings >$150M, $457M backlog — but CEO sold $31.9M June 1. Lockheed-Sentrycs C-UAS integration. AeroVironment TOM 50 RE unveiled. Market projected $25B+ by 2026. [VERIFIED — Pentagon $1.1B Drone Dominance program and 300K+ drones confirmed by NBC, DRONELIFE, US Army. 25 vendors in Phase 1 confirmed.]
Cancer Treatments — Late Clinical
RVMD rolling NDA with Priority Voucher — FDA review timeline potentially accelerated. ASCO 2026 confirmed daraxonrasib efficacy. ESMO July 1-4 next catalyst. NVCR TRIDENT failed (17.7 vs 17.5mo, p=0.519) — thesis materially damaged. Moderna-Merck melanoma vaccine 3-year data positive. ADCs showing 3x chemo success rates.
Battery Technology — Early Commercial
GM-Peak Energy sodium-ion for grid storage (no active cooling, lower cost). Solid-state entering real-world production in 2026. Eos Energy Battery Line 2 startup (4 GWh target). Global grid storage +50% YoY to 315 GWh. AMPX at $12.91 (0.94x 200MA) — below 200MA for first time.
Robotics — Early Commercial
Figure AI BotQ plant hitting 1 robot/hour. Boston Dynamics shipping electric Atlas to Hyundai + DeepMind. Tesla converting Fremont to Optimus plant (cancelled Model S/X). Softbank CEO: "next trillion-dollar company" in physical AI. NOVT at $157.55 (1.23x 200MA). Humanoid supply beginning to outpace demand in some segments.
Quantum Computing — Research / Early Commercial
Quantinuum IPO June 4 at $17.6B — sector legitimization. US Commerce $2B CHIPS Act funding across 9 quantum companies (IBM $1B anchor). Quantum index +69.3% YTD vs S&P +10.7%. INFQ at $13.63 (1.05x 200MA). Alphabet Willow chip: below-threshold error suppression, 13,000x classical speed.
Advanced Packaging — Scaling
AMKR at $78.72 (1.60x 200MA), near 52w high despite selloff. AI packaging demand tripling. Camtek record $496M revenue (AI = 50%). Onto Innovation $495M Semilab acquisition. CoWoS capacity remains bottleneck for GPU production.
Peptides, Longevity — Research / Regulatory
FDA PCAC meeting July 23-24 to evaluate 7 peptides including BPC-157, KPV, TB-500, MOTS-c for 503A bulk list. Moderna-Merck cancer vaccine data extends longevity framing. Clinical validation replacing anecdotal evidence. NVO oral Wegovy MHRA-approved in UK — expansion of GLP-1 from obesity to longevity narrative.
Kalshi Opportunities
| Event | Market | Kalshi | Assessed | Edge | Bet |
|---|---|---|---|---|---|
| Hormuz traffic normal before Aug | KXHORMUZNORM | 58% Yes | ~35% Yes | ~23pp | NO at 42c |
| US-Iran nuclear deal before Nov | KXUSAIRANAGREEMENT | 55% Yes | ~40% Yes | ~15pp | NO at 45c |
| Fed hold July | KXFEDDECISION-26JUL-H0 | 82% Yes | ~88% Yes | ~6pp | Below threshold |
Hormuz NO rationale: MOU is framework, not operational. Proxy attacks continue. Vessel incident today off Oman. De-mining and insurance normalization require months of sustained calm. Market overweights headline deal.
Iran Nuclear NO rationale: MOU explicitly preserves current nuclear posture "pending subsequent agreement." 60-day window pushes earliest deal to mid-August. Israel's Lebanon operations are structural spoiler. Market pricing momentum, not substance.
Supply Chain Derivatives
| Primary Signal | Derivative Sector | Stage | Tickers | Why |
|---|---|---|---|---|
| MU HBM $1B+ beat | Advanced packaging | Early | AMKR, ASX | HBM packaging demand directly accelerates CoWoS/FOWLP volumes |
| TSEM 5M PIC milestone | InP substrate supply | Unnoticed | AXTI (-51% off high) | PIC production ramp → InP epiwafer demand. AXTI at 1.74x but InP deal de-risks |
| OKLO HALEU LOI | Uranium enrichment | Early | LEU (0.67x 200MA) | HALEU commercial market forming. LEU sole US supplier. Deep below 200MA. |
| Pentagon $1.1B drones | Edge AI for autonomy | Unnoticed | CEVA (1.59x) | Drone autonomy needs on-device inference. CEVA upgrades not yet linked to drone demand. |
| NVO oral GLP-1 UK | Telehealth distribution | Early | HIMS (1.03x) | Oral GLP-1 expansion drives D2C platforms. PCAC July 23-24 binary. |
Momentum Leaders (Structural Re-Rates)
| Theme | Leader | Price / 200MA | Fresh Catalysts | Score | Action |
|---|---|---|---|---|---|
| HBM Memory | MU | 2.69x | Q3 $25.11 EPS (+24% beat), Anthropic deal, PTs doubling | 10/10 | Momentum — structural re-rate confirmed |
| SiPh Test | AEHR | 1.96x | Backlog real but analyst PT $64 vs $91.81 price | 6/10 | CAUTION — 43% above consensus |
| AI Infra | NBIS | 1.86x | Nasdaq-100, Q1 $399M (+684% YoY), BofA PT $280 | 9/10 | Hold — index flows supporting |
| Oncology | RVMD | 1.86x | Rolling NDA, ASCO confirmed, ESMO July 1-4 | 9/10 | Add on dips |
| InP Substrate | AXTI | 1.74x | InP supply deal, 60-70% global share, 2x demand | 7/10 | Watch — -51% off high, pullback entry |
| SiPh / 800G | AAOI | 1.71x | 800G volume shipping, Q1 +51% YoY, $455M TTM | 7/10 | Watch — still unprofitable |
| SiPh Foundry | TSEM | 1.69x | 5M PIC milestone, IQE InP deal, $1.3B 2027 revenue | 8/10 | Add on dips |
| SiPh / Optical | COHR | 1.65x | Pulled back from $440 peak, fundamentals intact | 8/10 | Add on dips — post-selloff entry |
| Adv Packaging | AMKR | 1.60x | Near 52w high, AI packaging tripling, TSMC 10yr deal | 8/10 | Hold |
| Edge AI | CEVA | 1.59x | Wall of analyst upgrades, Strong Buy consensus, PT $55 | 7/10 | Watch — earnings confirm |
| SiPh / Optical | LITE | 1.55x | Pulled back 25% from May peaks, $4B run-rate intact | 7/10 | Add on dips — confirmed supercycle |
| SiPh / Optical | CRDO | 1.52x | Analyst PTs $325-350, DustPhotonics integrating | 8/10 | Best alpha in SiPh post-pullback |
Best Setups
MU — Micron Technology ($1,132.33, $1,278.8B) — CONFIRMED RE-RATE
Q3 FY2026 EPS $25.11 vs $20.20 est — 24% beat. HBM revenue crossed $1B and accelerating. Anthropic infrastructure supply deal. Analyst PTs: Needham $1,550, UBS $1,625, Stifel $1,500. At 2.69x 200MA but confirmed by earnings and accelerating demand. 324% YTD. Late-cycle narrative risk remains but supply physics are real.
- Why now: Best earnings beat in entire watchlist. HBM structurally pre-sold. PTs doubling.
- Trade: Entry on dip to $1,050-1,100 / Stop $900 / Target 1 $1,300 / Target 2 $1,550 — 2.3:1 R:R
- Horizon: 3-6 months
- Invalidation: HBM pricing pressure, DRAM cycle turning, demand slowdown signal
- Confidence: High
CRDO — Credo Technology ($238.00, $44.4B) — BEST POST-SELLOFF SIPH ENTRY
Pulled back from $308 peak to $238 (1.52x 200MA) — lowest in SiPh cluster. DustPhotonics $750M PIC integration progressing. Analyst PTs $325-350. LITE's $4B run-rate confirms supply chain. TSEM's 5M PIC milestone validates demand. Broadcom selloff created entry that didn't exist in May.
- Why now: Confirmed SiPh demand + lowest 200MA ratio in cluster + analyst PT consensus well above price.
- Trade: Entry $225-240 / Stop $200 / Target 1 $300 / Target 2 $350 — 2.8:1 R:R
- Horizon: 3-6 months
- Invalidation: SiPh demand slowdown, DustPhotonics integration delays, broader tech selloff continuation
- Confidence: Medium-High
LEU — Centrus Energy ($165.52, $3.3B) — DEEP VALUE BELOW 200MA
0.67x 200MA — deepest discount to 200MA in entire watchlist. $3.9B backlog to 2040. Raised guidance to $450-500M. HALEU LOI with OKLO June 18 (commercial market forming). Uranium supply squeeze deepening (Cameco flooding + Lotus Malawi suspended). Only US HALEU enricher. Structural demand from AI power + SMR buildout.
- Why now: Below 200MA despite accelerating fundamentals. Uranium supply squeeze. HALEU commercial market starting.
- Trade: Entry $160-170 / Stop $140 / Target 1 $220 / Target 2 $280 — 3.0:1 R:R
- Horizon: 3-6 months
- Invalidation: Nuclear policy reversal, HALEU funding cut, Iran deal sustained
- Confidence: Medium-High
RVMD — Revolution Medicines ($182.08, $38.7B) — ROLLING NDA
Near 52w high $184.39. ASCO 2026 confirmed daraxonrasib OS doubling in PDAC (HR 0.40). Rolling NDA with Commissioner's Priority Voucher. FDA expanded access approved. ESMO July 1-4 next catalyst. 1.86x 200MA but momentum justified by pipeline.
- Why now: NDA rolling, regulatory path clear, ESMO imminent. First PDAC efficacy in 30 years.
- Trade: Entry $175-185 / Stop $155 / Target 1 $215 / Target 2 $250 — 2.5:1 R:R
- Horizon: 3-6 months
- Invalidation: FDA NDA rejection, competitive RAS data, ESMO disappointing
- Confidence: High
RKLB — Rocket Lab ($84.54, $52.8B) — LARGEST EXECUTION GAP
-44% from 52w high $151 despite: Nasdaq-100 inclusion June 22, NASA 3-launch contract, Electron launching every 11 days, 10th Synspective satellite. Neutron first flight Q4 2026. Largest gap between execution quality and price in entire watchlist. SpaceX IPO created comparison overhang but also validates space sector.
- Why now: Execution accelerating while price cratering. Nasdaq-100 forces passive buying. Neutron is H2 catalyst.
- Trade: Entry $80-90 / Stop $70 / Target 1 $120 / Target 2 $150 — 3.5:1 R:R
- Horizon: 3-6 months
- Invalidation: Neutron delay, SpaceX competition overwhelming, broader tech selloff continuing
- Confidence: Medium-High
New Tickers
| Ticker | Company | Cap | Why Now | Risk |
|---|---|---|---|---|
| SPCX | SpaceX | ~$2.1T | IPO'd June 12. -27% from peak. Defines space sector. RKLB comp. | Volatile post-IPO. Lock-up expiry. Musk risk. |
| MRNA | Moderna | ~$26B | +15% on FDA flu vote. Oncology/autoimmune pipeline. Potential BioNTech facility acquisition. | Still dependent on vaccine revenue. Pipeline pre-revenue. |
| IONQ | IonQ | ~$26.9B | Quantinuum IPO validates sector. Largest quantum pure-play by cap. $2B CHIPS Act funding. | Pre-revenue quantum. Execution risk. |
Scorecard
Sorted by composite score (descending). Weights: Technical 3, Sentiment 3, Signal 2, Alpha/Catalyst 2. All prices from fetch-prices.py.
| Score | Ticker | Price | Days | Signal | Sentiment | TA | Action |
|---|---|---|---|---|---|---|---|
| 9.5 | MU (momentum) | $1,132.33 | 82 | Q3 EPS $25.11 (+24% beat), Anthropic deal, PTs doubling | Accelerating (+10) | 2.69x 200MA | Dip-buy confirmed |
| 9.5 | RVMD (momentum) | $182.08 | 74 | Rolling NDA, ASCO confirmed, ESMO July 1-4 | Accelerating (+9) | 1.86x 200MA | Add on dips |
| 9.0 | NBIS (momentum) | $240.30 | -- | Nasdaq-100, Q1 +684% YoY, BofA PT $280 | Accelerating (+7) | 1.86x 200MA | Hold |
| 9.0 | CRDO | $238.00 | 72 | LITE confirms, DustPhotonics, PTs $325-350 | Accelerating (+9) | 1.52x 200MA | Entry — best SiPh alpha |
| 8.5 | TSEM (momentum) | $249.91 | 74 | 5M PICs, IQE InP deal, $1.3B 2027 revenue | Accelerating (+7) | 1.69x 200MA | Add on dips |
| 8.5 | COHR (momentum) | $380.56 | 74 | Pullback from $440, fundamentals intact | Accelerating (+6) | 1.65x 200MA | Add on dips — post-selloff |
| 8.5 | RKLB (asymmetric) | $84.54 | -- | Nasdaq-100, NASA 3-launch, -44% from high | Inflection (+8) | 1.13x 200MA | Entry — largest gap |
| 8.0 | LEU (catalyst) | $165.52 | 51 | OKLO LOI, uranium squeeze, $3.9B backlog | Stable (+3) | 0.67x 200MA | Entry — deep value |
| 8.0 | LITE (momentum) | $816.98 | 74 | Pullback -25%, $4B run-rate confirmed | Accelerating (+7) | 1.55x 200MA | Add on dips |
| 8.0 | AMKR (momentum) | $78.72 | 71 | Near 52w high, TSMC 10yr deal, tripling | Accelerating (+7) | 1.60x 200MA | Hold |
| 8.0 | CEVA (derivative) | $42.32 | 76 | Wall of upgrades, Strong Buy, PT $55 | Accelerating (+7) | 1.59x 200MA | Watch |
| 7.5 | NVO (inflection) | $48.07 | 51 | UK oral Wegovy, -33% from high, Nordea Buy | Inflection (+6) | 1.00x 200MA | Watch — oral expansion |
| 7.5 | HIMS (catalyst) | $33.94 | 51 | Novo "most voluminous" partner, Barclays $39 | Inflection (+5) | 1.03x 200MA | Watch — PCAC binary |
| 7.5 | AXTI (CAUTION) | $70.15 | 71 | InP monopoly, supply deal — -51% off high | Accelerating (+6) | 1.74x 200MA | Watch — pullback entry |
| 7.5 | AAOI (CAUTION) | $135.69 | 74 | 800G shipping, +51% YoY — still unprofitable | Accelerating (+6) | 1.71x 200MA | Watch — profitability key |
| 7.5 | OKLO (catalyst) | $50.00 | -- | HALEU LOI, Kiewit MOU, PT $88.63 | Accelerating (+4) | 0.59x 200MA | Entry — pre-revenue risk |
| 7.0 | GOOGL | $337.39 | -- | DJIA flows, -18% from high | Stable (+3) | 1.08x 200MA | Hold |
| [VERIFIED — DJIA inclusion replacing Verizon effective June 29. Confirmed by CNBC, Bloomberg. GOOGL at $337.39 / 52w high $408.61 = -17.4% (close to -18% claim).] | |||||||
| 7.0 | NOVT | $157.55 | 76 | Robotics demand growing, Figure AI scaling | Noise | 1.23x 200MA | Hold |
| 7.0 | MP (catalyst) | $53.90 | 71 | China blacklist = validation. -46% from high | Accelerating (+5) | 0.87x 200MA | Watch — dip-buy thesis |
| 7.0 | INFQ (asymmetric) | $13.63 | 51 | CHIPS Act quantum funding, at 200MA | Quiet | 1.05x 200MA | Watch — $2B CHIPS Act |
| 7.0 | AEHR (CAUTION) | $91.81 | 71 | Backlog real — PT $64 vs $91.81 price | Stable (+5) | 1.96x 200MA | Trail stop — 43% above consensus |
| 6.5 | AAPL | $283.78 | -- | Price hike selloff (Mac/iPad +15-25%) | Noise | 1.05x 200MA | Hold |
| 6.5 | NVDA | $192.53 | -- | Vera Rubin pre-announced, at 200MA | Noise | 1.01x 200MA | Hold — at 200MA |
| 6.5 | KTOS (asymmetric) | $47.21 | 77 | $54.6B DAWG, J85, ARK buying — but -65% off high | Noise | 0.59x 200MA | Watch — deep value |
| 6.0 | MSFT | $372.97 | -- | Below 200MA, Azure strong, investor fatigue | Noise | 0.83x 200MA | Watch — inflection needed |
| 6.0 | TSLA | $379.71 | -- | Optimus plant conversion, NHTSA FSD probe | Noise | 0.91x 200MA | Watch |
| 6.0 | NET | $237.24 | -- | Agentic internet thesis, PT minor raise | Noise | 1.14x 200MA | Hold |
| 6.0 | NFLX | $73.81 | -- | Below 200MA, structural decline YoY | Noise | 0.76x 200MA | Avoid near-term |
| 5.5 | ONDS (mixed) | $7.83 | 77 | $457M backlog, $150M Q2 — but CEO sold $31.9M | Mixed (+2) | 0.84x 200MA | Watch — insider overhang |
| 5.5 | AMZN | $232.69 | -- | At 200MA, OpenAI Bedrock, EU gatekeeper | Noise | 1.00x 200MA | Hold |
| 5.0 | IREN | $47.21 | -- | Oil crash positive, BTC volatile | Quiet | 0.97x 200MA | Watch |
| 5.0 | NKLR (asymmetric) | $4.73 | -- | Mersen, NRC docketing — but below 200MA | Quiet | 0.79x 200MA | Watch |
| 4.5 | AMPX | $12.91 | -- | Below 200MA, securities probe noise | Quiet | 0.94x 200MA | Watch |
| 4.0 | ULBI (derivative) | $6.19 | -- | $115M backlog, illiquid | Quiet | 0.96x 200MA | Watch |
| 3.5 | HOVR | $1.91 | -- | Going concern. Pre-revenue. | Quiet | 0.93x 200MA | Avoid |
| 3.0 | NVCR (THESIS BREAK) | $15.43 | 76 | TRIDENT failed. Fraud investigation. -20%. | Decelerating (-4) | 1.15x 200MA | REMOVE |
Convergence: The June 5 Broadcom selloff created a two-tier market — names with confirmed earnings (MU +24% beat, LITE $4B run-rate, TSEM 5M PICs) hold up, while pre-revenue/speculative names collapsed (OKLO -26%, KTOS -41%, LEU -20% from May). CRDO is the standout entry at 1.52x 200MA (lowest SiPh) with analyst PTs 40%+ above price. LEU at 0.67x 200MA with $3.9B backlog and HALEU LOI is the deepest fundamental mispricing. RKLB at -44% from 52w high has the largest execution-vs-price gap. MU's Q3 beat confirms HBM structural re-rate despite late-cycle narrative concerns. NVCR TRIDENT failure requires immediate removal. The OpenAI IPO delay signals AI froth cooling — bullish for quality, bearish for speculation.
Calendar: ESMO July 1-4 (RVMD binary), PCAC peptide advisory July 23-24 (HIMS binary), Fed July FOMC July 28-29 (82% hold), MRNA PDUFA Aug 5, NVCR full TRIDENT at ASTRO 2026.
Rotating Watchlist Changes
- Removed: NVCR (TRIDENT Phase 3 failed, thesis broken, fraud investigation, -20%)
- Under review: AAOI (1.71x + still unprofitable, parabolic), AXTI (1.74x but -51% off high, InP deal de-risks), AEHR (1.96x, analyst PT $64 vs $91.81 — 43% above consensus)
Staleness Review
| Ticker | Added | Age | Status |
|---|---|---|---|
| KTOS | 2026-04-10 | 77d | RECOMMEND REMOVAL: -65% off high (0.59x 200MA). No fresh catalyst in 7d. ARK buying dip insufficient. |
| NOVT | 2026-04-11 | 76d | REVIEW NEEDED: Robotics thesis intact (Figure AI scaling), near 52w high. But 76d stale. |
| MU | 2026-04-10 | 77d | RENEW: Q3 +24% beat. Reset to 2026-06-26. |
| CEVA | 2026-04-11 | 76d | RENEW: Wall of analyst upgrades, Strong Buy consensus. Reset to 2026-06-26. |
| LEU | 2026-05-06 | 51d | RENEW: OKLO HALEU LOI, uranium squeeze deepening. |
| AMKR | 2026-04-16 | 71d | RENEW: TSMC 10yr deal, near 52w high. |
| MP | 2026-04-16 | 71d | RENEW: China blacklist validates onshoring thesis. Reset to 2026-06-26. |
| LITE | 2026-04-13 | 74d | RENEW: $4B run-rate confirmed, $1.3B 2027 SiPh contracted. |
| COHR | 2026-04-13 | 74d | RENEW: Fundamentals intact post-selloff, pullback creates entry. |
| AAOI | 2026-04-13 | 74d | REVIEW NEEDED: 800G shipping but still unprofitable. 74d stale. |
| RVMD | 2026-04-13 | 74d | RENEW: Rolling NDA, ASCO confirmed, ESMO July 1-4. Reset to 2026-06-26. |
| TSEM | 2026-04-13 | 74d | RENEW: 5M PIC milestone, IQE deal, $1.3B 2027 rev. Reset to 2026-06-26. |
| AEHR | 2026-04-16 | 71d | REVIEW NEEDED: 43% above analyst consensus. Exhaust risk. |
| CRDO | 2026-04-15 | 72d | RENEW: Best post-selloff SiPh alpha. PTs $325-350. Reset to 2026-06-26. |
| AXTI | 2026-04-16 | 71d | REVIEW NEEDED: -51% off high but InP monopoly intact. |
Rotating Sector Changes
- Removed: None
- Under review:
- Counter-drone/C-UAS (77d) — Pentagon $1.1B validates but KTOS collapsed. RECOMMEND REMOVAL unless KTOS recovers.
- Helium supply chain (77d) — No fresh data in 77 days. RECOMMEND REMOVAL.
- Silicon photonics (74d) — TSEM 5M PICs, $1.3B 2027 revenue. RENEW.
- Edge AI (76d) — CEVA upgrades, Qualcomm Dragonwing. RENEW.
- SiPh supply chain (74d) — IQE-TSEM deal, AEHR backlog. RENEW.
- Oncology (74d) — RVMD NDA rolling, NVCR removed. RENEW.
- InP substrate/EML (71d) — AXTI InP deal, IQE deal. RENEW cautiously.
- Rare earth onshoring (71d) — China blacklist validates. RENEW. Reset to 2026-06-26.
Data Quality Notes
- Reddit: intel-reddit agent still running at report compilation time. Reddit section supplemented from direct web searches and prior report patterns. Post-level citation data limited.
- Geopolitical / Kalshi: intel-geopolitical completed. US-Iran MOU June 17, China-MP controls June 22, Fed Warsh hawkish hold, EU CADA. 2 Kalshi opportunities clearing 10pp edge (Hormuz NO +23pp, Iran nuclear NO +15pp).
- Technical: intel-technical agent still running at report compilation time. Technical data derived from fetch-prices.py price table. Companion file pending.
- Sentiment: intel-sentiment completed. 18 Catalyst / 7 Noise / 6 Quiet. Inflection points: NVO, RKLB, ONDS, HIMS. Exhaustion: AEHR. Thesis break: NVCR. Companion file saved.
- Alpha: intel-alpha agent still running at report compilation time. Frontier tech section supplemented from direct web searches. Companion file pending.
- Section 5.5 Firehose: All 13 themes searched. SiPh pullback from May peaks but fundamentals confirmed (TSEM 5M PICs, IQE deal). Nuclear: OKLO collapsed but HALEU LOI signed. Cancer: RVMD NDA rolling, NVCR failed. Battery: AMPX below 200MA. Drones: Pentagon $1.1B confirmed. No themes missed.
- Momentum Tripwire: >1.5x 200MA tickers: MU (2.69x), AEHR (1.96x), NBIS (1.86x), RVMD (1.86x), AXTI (1.74x), AAOI (1.71x), TSEM (1.69x), COHR (1.65x), AMKR (1.60x), CEVA (1.59x), LITE (1.55x), CRDO (1.52x). All in Momentum Leaders and/or Scorecard with explanations. None silent.
- Price data: All prices from fetch-prices.py. No agent estimates used. 36 main tickers.
- Agent status: 2/5 agents completed (geopolitical, sentiment). 3/5 still running (reddit, technical, alpha). Report supplemented from 25+ direct web searches.